Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 164,316 | 144,341 | 119,014 | 127,509 | 117,389 |
| Marketable Securities | 11,192 | N/A | N/A | N/A | N/A |
| Receivables | 105,653 | 106,472 | 105,811 | 94,245 | 98,718 |
| Inventories | 48,541 | 46,844 | 45,564 | 43,892 | 41,921 |
| Other current assets | 16,389 | 17,220 | 15,801 | 12,446 | 15,892 |
| TOTAL | $346,091 | $314,877 | $286,190 | $278,092 | $273,920 |
| Non-Current Assets | |||||
| PPE Net | 193,003 | 194,615 | 184,736 | 187,875 | 174,548 |
| Intangibles | 134,620 | 136,760 | 138,264 | 130,736 | 106,924 |
| Other Non-Current Assets | 91,438 | 90,817 | 96,950 | 104,641 | 100,916 |
| TOTAL | $419,061 | $422,192 | $419,950 | $423,252 | $382,388 |
| Total Assets | $765,152 | $737,069 | $706,140 | $701,344 | $656,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,450 | 12,765 | 12,585 | 13,084 | 10,917 |
| Accrued Expenses | 57,192 | 55,595 | 52,915 | 60,182 | 59,911 |
| Other current liabilities | 8,276 | 5,597 | 6,322 | 6,038 | 8,009 |
| TOTAL | $110,565 | $103,073 | $103,660 | $113,369 | $100,899 |
| Non-Current Liabilities | |||||
| Long Term Debt | 189,760 | 189,868 | 189,848 | 192,484 | 188,512 |
| Deferred Revenues | 25,248 | 24,997 | 23,629 | 27,029 | 22,062 |
| Other Non-Current Liabilities | 20,976 | 20,751 | 20,852 | 26,920 | 22,035 |
| TOTAL | $222,647 | $222,292 | $222,134 | $230,599 | $222,569 |
| Total Liabilities | $333,212 | $325,365 | $325,794 | $343,968 | $323,468 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,769 | 45,604 | 45,311 | 44,742 | 45,133 |
| Common Shares | 458 | 456 | 453 | 452 | 451 |
| Retained earnings | -173,530 | -193,121 | -213,682 | -233,036 | -250,541 |
| Other shareholders' equity | -3,960 | -1,129 | -9,223 | -11,768 | -16,156 |
| TOTAL | $431,940 | $411,704 | $380,346 | $357,376 | $332,840 |
| Total Liabilities And Equity | $765,152 | $737,069 | $706,140 | $701,344 | $656,308 |